243 related articles for article (PubMed ID: 30181159)
1. Type 2 Diabetes-Associated Genetic Variants Regulate Chromatin Accessibility in Human Islets.
Khetan S; Kursawe R; Youn A; Lawlor N; Jillette A; Marquez EJ; Ucar D; Stitzel ML
Diabetes; 2018 Nov; 67(11):2466-2477. PubMed ID: 30181159
[TBL] [Abstract][Full Text] [Related]
2. Genetic regulatory signatures underlying islet gene expression and type 2 diabetes.
Varshney A; Scott LJ; Welch RP; Erdos MR; Chines PS; Narisu N; Albanus RD; Orchard P; Wolford BN; Kursawe R; Vadlamudi S; Cannon ME; Didion JP; Hensley J; Kirilusha A; ; Bonnycastle LL; Taylor DL; Watanabe R; Mohlke KL; Boehnke M; Collins FS; Parker SC; Stitzel ML
Proc Natl Acad Sci U S A; 2017 Feb; 114(9):2301-2306. PubMed ID: 28193859
[TBL] [Abstract][Full Text] [Related]
3. Single-cell ATAC-Seq in human pancreatic islets and deep learning upscaling of rare cells reveals cell-specific type 2 diabetes regulatory signatures.
Rai V; Quang DX; Erdos MR; Cusanovich DA; Daza RM; Narisu N; Zou LS; Didion JP; Guan Y; Shendure J; Parker SCJ; Collins FS
Mol Metab; 2020 Feb; 32():109-121. PubMed ID: 32029221
[TBL] [Abstract][Full Text] [Related]
4. Functional characterization of T2D-associated SNP effects on baseline and ER stress-responsive β cell transcriptional activation.
Khetan S; Kales S; Kursawe R; Jillette A; Ulirsch JC; Reilly SK; Ucar D; Tewhey R; Stitzel ML
Nat Commun; 2021 Sep; 12(1):5242. PubMed ID: 34475398
[TBL] [Abstract][Full Text] [Related]
5. ATAC-seq reveals alterations in open chromatin in pancreatic islets from subjects with type 2 diabetes.
Bysani M; Agren R; Davegårdh C; Volkov P; Rönn T; Unneberg P; Bacos K; Ling C
Sci Rep; 2019 May; 9(1):7785. PubMed ID: 31123324
[TBL] [Abstract][Full Text] [Related]
6. Pancreatic islet chromatin accessibility and conformation reveals distal enhancer networks of type 2 diabetes risk.
Greenwald WW; Chiou J; Yan J; Qiu Y; Dai N; Wang A; Nariai N; Aylward A; Han JY; Kadakia N; Regue L; Okino ML; Drees F; Kramer D; Vinckier N; Minichiello L; Gorkin D; Avruch J; Frazer KA; Sander M; Ren B; Gaulton KJ
Nat Commun; 2019 May; 10(1):2078. PubMed ID: 31064983
[TBL] [Abstract][Full Text] [Related]
7. Allele-specific transcriptional activity at type 2 diabetes-associated single nucleotide polymorphisms in regions of pancreatic islet open chromatin at the JAZF1 locus.
Fogarty MP; Panhuis TM; Vadlamudi S; Buchkovich ML; Mohlke KL
Diabetes; 2013 May; 62(5):1756-62. PubMed ID: 23328127
[TBL] [Abstract][Full Text] [Related]
8. Glucocorticoid signaling in pancreatic islets modulates gene regulatory programs and genetic risk of type 2 diabetes.
Aylward A; Okino ML; Benaglio P; Chiou J; Beebe E; Padilla JA; Diep S; Gaulton KJ
PLoS Genet; 2021 May; 17(5):e1009531. PubMed ID: 33983929
[TBL] [Abstract][Full Text] [Related]
9. Integration of human pancreatic islet genomic data refines regulatory mechanisms at Type 2 Diabetes susceptibility loci.
Thurner M; van de Bunt M; Torres JM; Mahajan A; Nylander V; Bennett AJ; Gaulton KJ; Barrett A; Burrows C; Bell CG; Lowe R; Beck S; Rakyan VK; Gloyn AL; McCarthy MI
Elife; 2018 Feb; 7():. PubMed ID: 29412141
[TBL] [Abstract][Full Text] [Related]
10. From Genetic Association to Molecular Mechanisms for Islet-cell Dysfunction in Type 2 Diabetes.
Mattis KK; Gloyn AL
J Mol Biol; 2020 Mar; 432(5):1551-1578. PubMed ID: 31945378
[TBL] [Abstract][Full Text] [Related]
11. Genetic effects on liver chromatin accessibility identify disease regulatory variants.
Currin KW; Erdos MR; Narisu N; Rai V; Vadlamudi S; Perrin HJ; Idol JR; Yan T; Albanus RD; Broadaway KA; Etheridge AS; Bonnycastle LL; Orchard P; Didion JP; Chaudhry AS; ; Innocenti F; Schuetz EG; Scott LJ; Parker SCJ; Collins FS; Mohlke KL
Am J Hum Genet; 2021 Jul; 108(7):1169-1189. PubMed ID: 34038741
[TBL] [Abstract][Full Text] [Related]
12. Human pancreatic islet three-dimensional chromatin architecture provides insights into the genetics of type 2 diabetes.
Miguel-Escalada I; Bonàs-Guarch S; Cebola I; Ponsa-Cobas J; Mendieta-Esteban J; Atla G; Javierre BM; Rolando DMY; Farabella I; Morgan CC; García-Hurtado J; Beucher A; Morán I; Pasquali L; Ramos-Rodríguez M; Appel EVR; Linneberg A; Gjesing AP; Witte DR; Pedersen O; Grarup N; Ravassard P; Torrents D; Mercader JM; Piemonti L; Berney T; de Koning EJP; Kerr-Conte J; Pattou F; Fedko IO; Groop L; Prokopenko I; Hansen T; Marti-Renom MA; Fraser P; Ferrer J
Nat Genet; 2019 Jul; 51(7):1137-1148. PubMed ID: 31253982
[TBL] [Abstract][Full Text] [Related]
13. Whole-Genome Bisulfite Sequencing of Human Pancreatic Islets Reveals Novel Differentially Methylated Regions in Type 2 Diabetes Pathogenesis.
Volkov P; Bacos K; Ofori JK; Esguerra JL; Eliasson L; Rönn T; Ling C
Diabetes; 2017 Apr; 66(4):1074-1085. PubMed ID: 28052964
[TBL] [Abstract][Full Text] [Related]
14. Systematic analysis of the effects of genetic variants on chromatin accessibility to decipher functional variants in non-coding regions.
Wang D; Wu X; Jiang G; Yang J; Yu Z; Yang Y; Yang W; Niu X; Tang K; Gong J
Front Oncol; 2022; 12():1035855. PubMed ID: 36330496
[TBL] [Abstract][Full Text] [Related]
15. A Common Type 2 Diabetes Risk Variant Potentiates Activity of an Evolutionarily Conserved Islet Stretch Enhancer and Increases C2CD4A and C2CD4B Expression.
Kycia I; Wolford BN; Huyghe JR; Fuchsberger C; Vadlamudi S; Kursawe R; Welch RP; Albanus RD; Uyar A; Khetan S; Lawlor N; Bolisetty M; Mathur A; Kuusisto J; Laakso M; Ucar D; Mohlke KL; Boehnke M; Collins FS; Parker SCJ; Stitzel ML
Am J Hum Genet; 2018 Apr; 102(4):620-635. PubMed ID: 29625024
[TBL] [Abstract][Full Text] [Related]
16. (Epi)genomic heterogeneity of pancreatic islet function and failure in type 2 diabetes.
Lawlor N; Stitzel ML
Mol Metab; 2019 Sep; 27S(Suppl):S15-S24. PubMed ID: 31500827
[TBL] [Abstract][Full Text] [Related]
17. The miRNA profile of human pancreatic islets and beta-cells and relationship to type 2 diabetes pathogenesis.
van de Bunt M; Gaulton KJ; Parts L; Moran I; Johnson PR; Lindgren CM; Ferrer J; Gloyn AL; McCarthy MI
PLoS One; 2013; 8(1):e55272. PubMed ID: 23372846
[TBL] [Abstract][Full Text] [Related]
18. Laser capture microdissection of human pancreatic islets reveals novel eQTLs associated with type 2 diabetes.
Khamis A; Canouil M; Siddiq A; Crouch H; Falchi M; Bulow MV; Ehehalt F; Marselli L; Distler M; Richter D; Weitz J; Bokvist K; Xenarios I; Thorens B; Schulte AM; Ibberson M; Bonnefond A; Marchetti P; Solimena M; Froguel P
Mol Metab; 2019 Jun; 24():98-107. PubMed ID: 30956117
[TBL] [Abstract][Full Text] [Related]
19. Genetic risk converges on regulatory networks mediating early type 2 diabetes.
Walker JT; Saunders DC; Rai V; Chen HH; Orchard P; Dai C; Pettway YD; Hopkirk AL; Reihsmann CV; Tao Y; Fan S; Shrestha S; Varshney A; Petty LE; Wright JJ; Ventresca C; Agarwala S; Aramandla R; Poffenberger G; Jenkins R; Mei S; Hart NJ; Phillips S; Kang H; Greiner DL; Shultz LD; Bottino R; Liu J; Below JE; ; Parker SCJ; Powers AC; Brissova M
Nature; 2023 Dec; 624(7992):621-629. PubMed ID: 38049589
[TBL] [Abstract][Full Text] [Related]
20. Identification of a regulatory variant that binds FOXA1 and FOXA2 at the CDC123/CAMK1D type 2 diabetes GWAS locus.
Fogarty MP; Cannon ME; Vadlamudi S; Gaulton KJ; Mohlke KL
PLoS Genet; 2014 Sep; 10(9):e1004633. PubMed ID: 25211022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
